RCMI Coordinating Center (RCMI CC) Header Logo

Nikia Laurie

Concepts (70)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Retinoblastoma
8
2015
16
2.790
Why?
Retinal Neoplasms
5
2015
11
1.950
Why?
MicroRNAs
3
2015
386
1.020
Why?
Proto-Oncogene Proteins
2
2007
229
0.530
Why?
Nuclear Proteins
2
2007
287
0.520
Why?
Gene Expression Regulation, Neoplastic
3
2015
781
0.450
Why?
RNA, Neoplasm
1
2012
25
0.450
Why?
Cell Proliferation
2
2015
1149
0.410
Why?
Optic Nerve
1
2009
28
0.360
Why?
Cell Line, Tumor
6
2015
2128
0.330
Why?
Tumor Suppressor Protein p53
2
2007
200
0.320
Why?
Proto-Oncogene Proteins c-mdm2
1
2007
39
0.310
Why?
Topotecan
1
2005
4
0.280
Why?
Liver Neoplasms, Experimental
1
2005
21
0.280
Why?
Cell Adhesion Molecules
1
2005
70
0.270
Why?
Antigens, CD
1
2005
116
0.270
Why?
Disease Models, Animal
1
2005
1300
0.190
Why?
Mice
4
2012
5668
0.160
Why?
Xenograft Model Antitumor Assays
2
2009
242
0.150
Why?
Rats
4
2009
3261
0.140
Why?
Animals
6
2012
14307
0.140
Why?
Humans
8
2015
34853
0.130
Why?
Cell Cycle Proteins
2
2007
220
0.130
Why?
Gene Expression Profiling
1
2015
600
0.100
Why?
Interferon-beta
1
2009
7
0.090
Why?
Dependovirus
1
2009
11
0.090
Why?
Cadherins
1
2009
82
0.090
Why?
Gene Transfer Techniques
1
2009
43
0.090
Why?
Genetic Vectors
1
2009
154
0.080
Why?
Cell Adhesion
1
2009
209
0.080
Why?
Neoplasm Invasiveness
1
2009
247
0.080
Why?
Tumor Cells, Cultured
1
2009
480
0.080
Why?
Apoptosis
2
2005
1317
0.080
Why?
Disease Progression
1
2009
580
0.080
Why?
Tumor Suppressor Protein p14ARF
1
2006
11
0.070
Why?
Gene Amplification
1
2006
24
0.070
Why?
Retinoblastoma Protein
1
2006
27
0.070
Why?
Imidazoles
1
2006
124
0.070
Why?
Cell Growth Processes
1
2005
41
0.070
Why?
Vincristine
1
2005
13
0.070
Why?
Carboplatin
1
2005
13
0.070
Why?
Piperazines
1
2006
109
0.070
Why?
G1 Phase
1
2005
32
0.070
Why?
Etoposide
1
2005
21
0.070
Why?
Cell Division
1
2006
296
0.070
Why?
Cell Line
1
2009
1289
0.070
Why?
S Phase
1
2005
36
0.070
Why?
Rats, Sprague-Dawley
2
2009
1534
0.070
Why?
Cell Death
1
2006
260
0.070
Why?
Protein Isoforms
1
2005
121
0.070
Why?
Hepatocytes
1
2005
74
0.070
Why?
Drug Synergism
1
2005
171
0.070
Why?
Eye
1
2005
68
0.070
Why?
Drug Therapy, Combination
1
2005
217
0.070
Why?
Animals, Newborn
1
2005
323
0.060
Why?
DNA Damage
1
2006
341
0.060
Why?
Retina
1
2006
255
0.060
Why?
Mice, Knockout
1
2005
897
0.060
Why?
Gene Expression
1
2005
639
0.060
Why?
Dose-Response Relationship, Drug
1
2005
984
0.050
Why?
Cell Survival
1
2005
818
0.050
Why?
Mice, Inbred C57BL
1
2006
1530
0.050
Why?
Female
2
2012
19873
0.050
Why?
Time Factors
1
2005
1681
0.050
Why?
Antineoplastic Agents
1
2005
756
0.040
Why?
Adult
1
2012
11034
0.040
Why?
Male
1
2012
18870
0.030
Why?
Transplantation, Heterologous
1
2009
87
0.020
Why?
Neoplasm Transplantation
1
2009
114
0.020
Why?
Child
1
2009
2875
0.010
Why?
Laurie's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (70)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support